Radiotherapy quality assurance review in a multi-center randomized trial of limited-disease small cell lung cancer: The Japan Clinical Oncology Group (JCOG) trial 0202

Radiation Oncology

Volumn 4, Issue , 2009, Pages

  Sanuki Fujimoto, Naoko ^a   Ishikura, Satoshi ^a   Hayakawa, Kazushige ^a   Kubota, Kaoru ^b   Nishiwaki, Yutaka ^b   Tamura, Tomohide ^b  

^a NATIONAL CANCER CENTER   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; ETOPOSIDE; IRINOTECAN; ANTINEOPLASTIC AGENT;

ARTICLE; CANCER SIZE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; JAPAN; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MULTICENTER STUDY; MULTIPLE CYCLE TREATMENT; PATIENT SELECTION; PHASE 3 CLINICAL TRIAL; QUALITY CONTROL; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; SPINAL CORD; HEALTH CARE QUALITY; LUNG TUMOR; MULTIMODALITY CANCER THERAPY; RADIOTHERAPY; STANDARD;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; HUMANS; JAPAN; LUNG NEOPLASMS; QUALITY ASSURANCE, HEALTH CARE; RADIOTHERAPY; SMALL CELL LUNG CARCINOMA;

EID: 67749112003     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-4-16     Document Type: Article

References (13)

1. White JE Chen T McCracken J Kennedy P Seydel HG Hartman G Mira J Khan M Durrance FY Skinner O The influence of radiation therapy quality control on survival, response and sites of relapse in oat cell carcinoma of the lung: Preliminary report of a Southwest Oncology Group study Cancer 1982, 50:1084-1090 10.1002/ 1097-0142(19820915)50:6<1084::AID-CNCR2820500611>3.0.CO;2-W 6286086
2. Abrams RA Winter KA Regine WF Winter KA Regine WF Safran H Hoffman JP Konski AA Benson AB Macdonald JS Rich TA Willett CG RTOG 9704 - Radiotherapy quality assurance (QA) review and survival Proceedings of the 48th Annual Meeting of the American Society for Therapeutic Radiology and Oncology 2006, 66(Suppl):S22
3. Fabian J Mansfield C Dahlberg S Jones SE Miller TP Van Slyck E Grozea PN Morrison FS Coltman CA Jr Fisher RI Low-dose involved field radiation after chemotherapy in advanced Hodgkin disease. A Southwest Oncology Group Randomized Study Ann Intern Med 1994, 120:903-912 8172436
4. Wallner E Lustig RA Pajak TF Robinson G Davis LW Perez CA Seydel HG Marcial VA Laramore GE Impact of initial quality control review on study outcome in lung and head/neck cancer studies-review of the Radiation Therapy Oncology Group experience Int J Radiat Oncol Biol Phys 1989, 17:893-900 2674086
5. Perez C Stanley K Rotman M Grundy G Hanson W Rubin P Kramer S Brady Impact of irradiation technique and tumor extent in tumor control and survival of patients with unresectable non-oat cell carcinoma of the lung: Report by the Radiation Therapy Oncology Group Cancer 1982, 50:1091-1099 10.1002/ 1097-0142(19820915)50:6<1091::AID-CNCR2820500612>3.0.CO;2-0 6286087
6. Atagi S Kawahara M Tamura Noda K Watanabe K Yokoyama A Sugiura T Senba H Ishikura S Ikeda H Ishizuka N Saijo N Standard thoracic radiotherapy with or without concurrent daily low-dose carboplatin in elderly patients with locally advanced non-small cell lung cancer: A phase III trial of the Japan Clinical Oncology Group (JCOG9812) Jpn J Clin Oncol 2005, 35:195-201 10.1093/jjco/hyi060 15845568
7. Muller RP Eich HT The development of quality assurance programs for radiotherapy within the German Hodgkin Study Group (GHSG). Introduction, continuing work, and results of the radiotherapy reference panel Strahlenther Onkol 2005, 181:557-66 10.1007/s00066-005-1437-0 16170482
8. Eich HT Engenhart-Cabillic R Hansemann K Lukas P Schneeweiss A Seegenschmiedt H Skripnitchenko R Staar S Willich N Müller RP Quality control of involved field radiotherapy in patients with early-favorable (HD10) and early-unfavorable (HD11) Hodgkin's lymphoma. An analysis of the German Hodgkin Study Group Int J Radiat Oncol Biol Phys 2008, 71:1419-1424 18234433
9. Schaake-Koning C Kirkpatric A Bartelink H Kroger R van Zandwijk N The need for immediate monitoring of treatment parameters and uniform assessment of patient data in clinical trials: A quality control study of the EORTC Radiotherapy and Lung Cancer Cooperative Groups Eur J Cancer 1991, 27:615-619 1647185
10. Izewska J Bera P Vatnitsky S IAEA/WHO TLD postal dose audit service and high precision measurements for radiotherapy level dosimetry. International Atomic Energy Agency/World Health Organization Radiat Prot Dosimetry 2002, 101(1-4):387-92 12382774
11. Ferreira IH Dutreix A Bridier A Chavaudra J Svensson H The ESTRO-QUALity assurance network (EQUAL) Radiother Oncol 2000, 55(3):273-84 10.1016/ S0167-8140(99)00101-2 10869742
12. Aguirre JF Tailor R Ibbott G Stovall M M Hanson W Thermoluminescence Dosimetry as a Tool for the Remote Verification of Output for Radiotherapy Beams: 25 Years of Experince. Standards and Codes of Practice in Medical Radiation Dosimetry Proceedings of an International Symposium, IAEA, Vienna 2002:191-199
13. Nishio T Kunieda E Shirato H Ishikura S Onishi H Tateoka K Hiraoka M Narita Y Ikeda M Goka T Dosimetric verification in participating institutions in a stereotactic body radiotherapy trial for stage I non-small cell lung cancer: Japan clinical oncology group trial (JCOG0403) Phys Med Biol 2006, 51(21):5409-17 10.1088/0031-9155/51/21/ 002 17047260